AMIFAMPRIDINE for Neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where AMIFAMPRIDINE was used for Neoplasm.
Most Reported Side Effects for AMIFAMPRIDINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 298 | 12.3% | 10 | 55 |
| Asthenia | 292 | 12.1% | 23 | 110 |
| Paraesthesia | 260 | 10.7% | 8 | 38 |
| Paraesthesia oral | 199 | 8.2% | 3 | 21 |
| Fall | 194 | 8.0% | 18 | 105 |
| Nausea | 168 | 6.9% | 10 | 50 |
| Muscular weakness | 155 | 6.4% | 10 | 55 |
| Fatigue | 154 | 6.4% | 9 | 39 |
| Condition aggravated | 153 | 6.3% | 9 | 63 |
| Headache | 149 | 6.2% | 2 | 36 |
| Dyspnoea | 139 | 5.7% | 12 | 74 |
| Diarrhoea | 134 | 5.5% | 6 | 40 |
| Dizziness | 126 | 5.2% | 1 | 21 |
| Myasthenic syndrome | 118 | 4.9% | 19 | 57 |
| Off label use | 116 | 4.8% | 6 | 24 |
Other Indications for AMIFAMPRIDINE
Myasthenic syndrome (2,164)
Congenital myasthenic syndrome (74)
Myasthenia gravis (39)
Product used for unknown indication (35)
Muscular weakness (9)
Small cell lung cancer limited stage (6)
Other Drugs Used for Neoplasm
BEVACIZUMAB (502)
ATEZOLIZUMAB (404)
CYCLOPHOSPHAMIDE (385)
CARBOPLATIN (283)
PACLITAXEL (267)
NIVOLUMAB (219)
OXALIPLATIN (185)
PEMBROLIZUMAB (173)
LENALIDOMIDE (171)
DOXORUBICIN (150)